| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.23 | 0.1 |